Mangalam Drugs & Organics, one of the leading Pharma/API Company has successfully completed the expansion/ modernization work of its Plant on Unit-2 situated at Vapi. The company has also commenced the trial operations at this newly expanded Unit-2 situated at Vapi on August 22, 2016. The company also takes pride in announcing that it has completed this project in record time. The total cost of the expansion is around Rs 30 crore.
The plant will produce the API's for Malaria and ARV's. The company will be filing DMF's for all its product with WHO Geneva. It also plans to file DMF's of certain API's with USFDA in the due course of time.
Mangalam Drugs & Organics is a part of the MangalamGroup, manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a in-house Research and Development (R&D) Base.
